Wuerth While Wily Wakenings: The 16 Largest Israeli Cos Reporting in ISLs Generated Total 1Q 2022 Bottom-Line Profits Which Declined By 4% From That in the 1Q 2021. Excluding Teva Pharmaceuticals, Which Experienced a 1Q 2022 Earnings Deterioration of ISL 3.3 Bil or of 1207% Due Overwhelmingly To Losses From Legal Settlements and Loss Contingencies, the Remaining 15 Israeli Cos Saw Their 1Q 2022 Total Profits Increase By a Very Impressive 45% From That in the 1Q 2021.

Saturday, July 30, 2022

The 16 Largest Israeli Cos Reporting in ISLs Generated Total 1Q 2022 Bottom-Line Profits Which Declined By 4% From That in the 1Q 2021. Excluding Teva Pharmaceuticals, Which Experienced a 1Q 2022 Earnings Deterioration of ISL 3.3 Bil or of 1207% Due Overwhelmingly To Losses From Legal Settlements and Loss Contingencies, the Remaining 15 Israeli Cos Saw Their 1Q 2022 Total Profits Increase By a Very Impressive 45% From That in the 1Q 2021.

From a review of the investing.com website and the companiesmarketcap.com website, I identified the 30 Israeli Companies with recent stock market caps above ILS 10 Bil.

Of these 30 largest Israeli Companies, 14 of them reported their profits in US$s and the other 16 reported their profits in Israeli New Shekels (ISLs).

And from a review of the wallstreetjournalmarkets.com and investing.com websites and also from Company Internal Relations websites, the table below shows the Consolidated Net Profits (Losses) from Continuing Operations for the first quarters of both 2022 and 2021 for each of these 16 largest Israeli Companies reporting their profits in ISLs.